With capital being scarce in the cannabis sector, Cannabis-RX provides a unique combination of services, including $30 million in available capital for potential tenants. Though the feds have given guidance for banks on how to deal with marijuana focused businesses, operators have had a difficult time opening bank accounts and establishing lines of credit, which is where Kylo and Cannabis-RX step in. “What separates us from a standard real estate company is that we can provide the facility, as well as some of the startup or expansion capital.”

Kylo mentioned that he is evaluating future opportunities in Phoenix, Arizona, and Washington, but was unable to share any more public information about those deals. “We have to be able to make money from a deal strictly from a real estate perspective” before considering the potential for a canna-business to become a tenant.

Like many other marijuana businesses Cannabis-RX is optimistic about the future of marijuana policy in florida. In January, the firm paid $1.26 million for a light industrial facility in Sarasota.

After current renovations are complete, Kylo is confident that the building would, if they choose to sell, be able to resell for $5 million or more, so “whether or not we [Cannabis-RX] actually put a licensed marijuana grower in the facility, or we just sell it, we love out options. If there is an opportunity to put a cannabis operator in the facility we will absolutely do it, and if not, we will sell it and move on.”

Compared to other companies in the space, Cannabis-RX has been quite transparent. Many marijuana based businesses trading on the OTC markets provide minimal financial disclosure, but since Longview Real Estate became Cannabis-RX in February, the company has filed seven SEC reports that include important financial information for investors.

When asked about the general behavior of the cannabis market, Kylo noted the issue of differing federal and state policies. “When, and if, the federal and state discrepancy is solved, it will go a long way to tame the volatility in the market. It is a new industry and the kinks are still being ironed out, which is a big part of the volatility.”

To follow cannabis industry developments and investment opportunities, click here to access 420 Investor Alan Brochstein's “Guide to Cannabis Stocks.”